FDA Approved: VUMERITY — Supplemental Application (Biogen Inc.)

View source ↗

Summary

FDA approved Biogen's supplemental application for VUMERITY (diroximel fumarate), updating/expanding its labeling for the treatment of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• VUMERITY (diroximel fumarate)

Snippet

SUPPL AP for VUMERITY (DIROXIMEL FUMARATE)